The promotive effect of ERs in NSCLC progression was achieved by modulating the signaling network composed of EGFR, Notch1, GSK3β/β-Catenin pathways, and then regulating cell proliferation, mobility and apoptosis. Here, NOTCH1 is linked to non-small cell lung carcinoma.